金浦鈦業(000545.SZ):子公司終止對外投資事項
格隆匯4月7日丨金浦鈦業(000545.SZ)公佈,2023年7月13日召開第八屆董事會第十七次會議,審議通過了《關於全資子公司對外投資設立參股公司的議案》,同意公司全資子公司南京鈦白化工有限責任公司(以下簡稱“南京鈦白”)與蘭州金川科技園有限公司(以下簡稱“金川科技園”)、甘肅鎳都產業投資基金(有限合夥)(以下簡稱“鎳都產業基金”)共同投資設立參股公司,註冊資本5億元,其中金川科技園出資4億元、南京鈦白和鎳都產業基金分別出資5000萬元。綜合考慮南京鈦白的資金現狀,以及磷酸鐵項目暫緩的狀態,公司擬終止上述對外投資項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.